Monitoring Force Group

Monitoring Force Group is a France-based company that positions itself as a strategic partner for the clinical development of health products. According to its official website, the company offers an integrated range of services covering each phase of a health product development project, with the stated goal of delivering reliable results that comply with international standards and meet client deadlines. Its service portfolio spans interventional clinical studies (phases I to IV), non-interventional studies, patient centricity programmes (PSP), regulatory affairs, biometry, and market access. The company is headquartered in Maisons-Laffitte, France, and presents itself as supporting projects under French, European, and international regulations. The firm's core activity is clinical research organisation (CRO) work and related consulting. For interventional studies, Monitoring Force Group describes complete management from design and implementation through to delivery of the clinical study report, with rigorous planning and efficient execution. Its non-interventional studies are presented as a way to generate real-world data on the use of medicines and medical devices, improving understanding of their effectiveness and safety. The patient centricity programme is described as integrating patient needs through patient-centred programmes that provide continuous support and actively involve patients in their care pathways. Regulatory services include the submission and obtaining of authorisation dossiers for launching all types of studies on all types of health products, in accordance with regulations in force in France, Europe, and worldwide, as well as ensuring regulatory compliance and monitoring regulatory developments. Biometry services cover clinical data management and statistical analysis, including data entry, verification, validation, data reconciliation, and in-depth statistical analyses. Market access services are also offered to help clients navigate the relevant processes. Monitoring Force Group is a relatively low-profile commercial entity. Public structured data identifies it as a company located in Maisons-Laffitte, France. Its official website is the primary public source describing its service offering. The company appears to operate in the life sciences services sector, serving pharmaceutical, biotechnology, and medical device sponsors that need support with clinical trials, regulatory submissions, and market access. No founding date, ownership structure, or executive leadership details are available in the supplied evidence, and the company's legal form and listing status are not specified.

Monitoring Force Group is a French company headquartered in Maisons-Laffitte, France. Public structured data identifies it as a company in that location, and its official website describes its activities in clinical research and regulatory support for health products. The available evidence does not include a founding date, founding story, ownership history, or major corporate events. The company presents itself as a strategic partner for clinical development, offering integrated services across interventional studies, non-interventional studies, patient centricity programmes, regulatory affairs, biometry, and market access. Its stated focus is on supporting projects in compliance with French, European, and international regulations. As of the available evidence, the company appears to be active and operating in the life sciences services sector, but further historical details are not documented in the supplied sources.

A strategic partner for every stage of clinical development, offering integrated services to ensure quality, compliance, and innovation in health projects.

• Interventional clinical studies (Phase I–IV)

  Complete management from design and implementation to delivery of the clinical study report, with rigorous planning and efficient execution.

• Non-interventional studies

  Studies providing real-world data on the use of medicines and medical devices, improving understanding of their effectiveness and safety.

• Patient centricity programme (PSP)

  Integration of patient needs through patient-centred programmes offering continuous support and active involvement in care pathways.

• Regulatory affairs

  Submission and obtaining of authorisation dossiers for launching all types of studies on all types of health products, in compliance with French, European, and international regulations; ensuring regulatory compliance and monitoring regulatory developments.

• Biometry

  Clinical data management and statistical analysis covering data entry, verification, validation, data reconciliation, and in-depth statistical analyses.

• Market access

  Services to help clients navigate market access processes.

1. 1Accompagnement Stratégique pour Produits de Santémonitoringforcegroup.com
2. 2Partenaire Stratégique Développement Cliniquemonitoringforcegroup.com
3. 3Monitoring Force Group (France) - Wikidatawikidata.org